GlycoMimetics, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
14.51
+1.24 (9.34%)
Jun 18, 2025, 2:21 PM - Market open
GlycoMimetics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for GlycoMimetics stock has a target of 22, which predicts a 51.62% increase from the current stock price of 14.51.
Price Target: $22 (+51.62%)
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for GlycoMimetics is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 3 | 3 | 3 | 3 | 3 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
LifeSci Capital | LifeSci Capital | Buy Initiates $22 | Buy | Initiates | $22 | +51.62% | Jun 18, 2025 |
Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2021 |
Raymond James | Raymond James | Buy Maintains $285 → $270 | Buy | Maintains | $285 → $270 | +1,760.79% | Aug 6, 2021 |
Raymond James | Raymond James | Buy Maintains $270 → $285 | Buy | Maintains | $270 → $285 | +1,864.16% | Apr 29, 2021 |
Piper Sandler | Piper Sandler | Buy Initiates $225 | Buy | Initiates | $225 | +1,450.65% | Feb 10, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.